Bringing brilliant ideas to life - and to market

UCL’s truly exceptional research deserves a chance to change the world, with the expert support to make it happen.

man and older woman look at ipad in lab coats

198

companies since 1993

£4.5bn

capital raised since 2016

1400+

patents filed since 1993

8700+

licences since 1993

Working side by side with UCL academics

As UCL’s expert commercialisation partner, we provide tailored support and specialist expertise to help researchers, clinicians and academics take ideas and technologies beyond the university.

UCL Ventures helps make your idea market-ready with expert advice, strategic commercial insight, and practical support to help realise the full commercial and social value of your research.

Curious about taking your research to market?

Whether you’re at the earliest stage of an idea and want to understand its commercial viability, or preparing to launch a spinout, a serial academic entrepreneur or simply dipping your toe into the commercial world, we guide you carefully and collaboratively.

Commercialisation can feel unfamiliar, so we’ve broken down how it works:

How we work with you What you can expect

There are multiple routes to take your research to market - explore them here:

Create a company License your invention Routes to social impact Protect your idea

Ways we can support you on your journey to market:

Helpful tools & resources Common questions Inspiring stories

30 years' experience

UCL Ventures: a powerhouse of commercialisation

Based in Bloomsbury, at the heart of London’s innovation ecosystem, UCL Ventures brings specialist commercial, scientific and investment expertise to every stage of the journey from invention to market.

We harness UCL’s innovations to deliver substantial impact, strong investor returns, and high‑quality ventures shaping the future.

Learn more about UCL Ventures

Explore our portfolio

Our extensive portfolio of spinouts and technologies spans departments, disciplines and sectors.

Gigaton

Energy & cleantech

Gigaton

Mission to reduce global emissions at gigatonne scale.

Endomag

Oncology, Medtech

Endomag

Medical devices for surgical guidance in breast cancer and more.

Autolus Therapeutics

Drug discovery, Oncology

Autolus Therapeutics

Developing next-generation programmed T-cell therapies for cancer.

UCL Ventures recognised that time was of the essence. Their team really cared about our story, and what it meant for us to spin out, and I will never forget that.
Dr Maria Leiloglou, CEO and founder of Enacuity